Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Vegan collagen builder improves hair growth, skin smoothness, and reduces wrinkles and pain.

Adding hyaluronic acid helps create larger artificial hair follicles in the lab.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Warfarin can rarely cause hair loss, which is usually reversible.

MorrF improves hair growth better than minoxidil alone.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Multiple treatments work best for hair loss.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Hair loss needs more research for better treatments.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.